Evidence map›Paper›PMID 31636883›Full record

ArticleTherapeutic advances in drug safety2019

Deferasirox in thalassemia: a comparative study between an innovator drug and its copy among a sample of Iraqi patients.

Aqil M Daher, Hayder Al-Momen, Shaymaa Kadhim Jasim

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Therapeutic advances in drug safety, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Trial
  2. Twin pregnancy: adolescents versus adults.Journal of the Turkish German Gynecological Association · 2025
    Article
  3. Obstetric and Neonatal Outcomes in Overweight Adolescent Pregnant Mothers.Journal of obstetrics and gynaecology of India · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Aqil M DaherDepartment of Community Medicine, Faculty of Medicine and Defense Health, National Defense University of Malaysia, Kuala Lumpur, 57000, Malaysia.ORCID https://orcid.org/0000-0002-3504-4340
Hayder Al-MomenDepartment of Pediatrics, Al-Kindy College of Medicine, University of Baghdad, Baghdad, Iraq.
Shaymaa Kadhim JasimDepartment of Obstetrics and Gynecology, College of Medicine, University of Baghdad, Baghdad, Iraq.
University of Baghdad · IQNational Defence University of Malaysia · MY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe health care industry is witnessing an increasing trend in the use of generic medicines because of their presumed low cost compared with innovator medicines. The aim of this study was to determine and compare the performance of the copy drug Osveral

methodsA prospective observational study including 223 patients receiving the branded medicine Exjade

resultsThe median age of the sample was 8 years. There was no significant difference in gender distribution between the two groups (

conclusionsExjade

Indexed as

copydeferasiroxIraqthalassemia

Identifiers

PMID31636883
PMCPMC6785916
OpenAlexW2980119492

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.